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Abstract
Background: Postnatal growth and repair of skeletal muscle relies upon a population of quiescent muscle precursor
cells, called satellite cells that can be activated to proliferate and differentiate into new myofibers, as well as self-renew to
replenish the satellite cell population. The balance between differentiation and self-renewal is critical to maintain muscle
tissue homeostasis, and alterations in this equilibrium can lead to chronic muscle degeneration. The transcription
factor CCAAT/enhancer binding protein beta (C/EBPβ) is expressed in Pax7+ satellite cells of healthy muscle and
is downregulated during myoblast differentiation. Persistent expression of C/EBPβ upregulates Pax7, inhibits MyoD, and
blocks myogenic differentiation.
Methods: Using genetic tools to conditionally abrogate C/EBPβ expression in Pax7+ cells, we examined the
role of C/EBPβ in self-renewal of satellite cells during muscle regeneration.
Results: We find that loss of C/EBPβ leads to precocious differentiation at the expense of self-renewal in primary
myoblast and myofiber cultures. After a single muscle injury, C/EBPβ-deficient satellite cells fail to self-renew resulting in a
reduction of satellite cells available for future rounds of regeneration. After a second round of injury, muscle regeneration
is impaired in C/EBPβ conditional knockout mice compared to wild-type control mice. We find that C/EBPβ can regulate
Notch2 expression and that restoration of Notch activity in myoblasts lacking C/EBPβ prevents precocious differentiation.
Conclusions: These findings demonstrate that C/EBPβ is a novel regulator of satellite cell self-renewal during muscle
regeneration acting at least in part through Notch2.
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Background
Skeletal muscle has a remarkable capacity to regenerate
after injury, which depends on the presence of muscle
progenitor cells, called satellite cells (SC) [1, 2]. In adult
muscle, satellite cells make up 2–7% of all myonuclei and
express the paired-box transcription factor Pax7 [3–6].
After myofiber damage, SCs quickly upregulate the myo-
genic regulatory factor MyoD and re-enter the cell cycle
to give rise to a population of transient-amplifying
cells [7–9]. Subsequently, they downregulate Pax7,
irreversibly withdraw from the cell cycle, upregulate
myogenin expression, commit to terminal differenti-
ation, and fuse to repair damaged fibers or to create new
ones [8, 10–12]. While a large majority of myoblasts will
differentiate into myocytes, a small percentage of myoblasts
escape differentiation by maintaining Pax7 expression,
downregulating MyoD expression, and returning to mitotic
quiescence [1, 13]. As such, the expression of Pax7 and
MyoD allows for classification of SCs as self-renewing
(Pax7+/MyoD−), proliferating (Pax7+/MyoD+), or differenti-
ating (Pax7−/MyoD+) [11, 13–15]. Self-renewal is important
for maintaining the precursor pool and transplantation of
SCs, or single muscle fibers can contribute to the repair of
hundreds of new muscle fibers [1, 16] and replenishment of
the stem cell niche [17].
CCAAT/enhancer binding proteins (C/EBPs) are a
family of transcription factors that regulate cellular
growth and differentiation, metabolism, and inflamma-
tion [18]. In skeletal muscle, C/EBPβ expression is local-
ized to Pax7+ SCs of healthy muscle and is rapidly
downregulated upon induction to differentiate [19, 20].
In vivo, loss of C/EBPβ expression in SCs resulted in
larger muscle fiber cross-sectional area, fewer fibers, and
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improved repair after a single acute muscle injury
[19, 20]. When overexpressed in the murine myoblast
cell line C2C12 or in primary myoblasts, C/EBPβ re-
duced MyoD and other myogenic protein levels dur-
ing differentiation, in addition to reducing myoblast
fusion. C/EBPβ also increased Pax7 protein expression
suggesting that C/EBPβ acts to maintain myogenic
progenitors in an undifferentiated state [19, 21].
In this study, we examined the role of C/EBPβ in SC
self-renewal using conditional knockout mice (Cebpbfl/
flPax7CreER/+) in which C/EBPβ is knocked down in Pax7+
cells following activation of the CreER recombinase with
tamoxifen [19–23]. Loss of C/EBPβ in SCs results in pre-
cocious differentiation at the expense of self-renewal in
both primary myoblasts and myofiber cultures. Further,
C/EBPβ-deficient SCs are unable to self-renew after
muscle injury leading to a reduction in the SC pool such
that it cannot efficiently support muscle regeneration after
a second round of injury. Mechanistic studies revealed
that C/EBPβ can regulate Notch2 expression and self-
renewal can be rescued in C/EBPβ-deficient myoblasts by
overexpression of the Notch intracellular domain (NICD)
indicating that C/EBPβ acts, at least in part, by regulating
Notch signaling. Taken together, these results establish C/
EBPβ as a novel regulator of SC homeostasis.
Methods
Mice and animal care
All animal work was performed in accordance with the
guidelines set out by the Canadian Council on Animal Care
and was approved by the University of Ottawa Animal Care
Committee. A mouse bearing a C/EBPβ-floxed allele (C/
EBPβfl/fl) [22] was crossed with mice bearing the Pax7-
CreERtm allele [23] to generate C/EBPβfl/flPax7+/+ (wild-
type, WT) and conditional null C/EBPβ−/−Pax7CreER−/+ (C/
EBPβ−/−) animals as previously described [19]. All animals
were housed in a controlled facility (22 °C with 30% relative
humidity on a 12-h light/dark cycle) and provided with
food and water ad libitum. In vivo induction of CreERtm
activity, for myofiber and muscle injury experiments, was
accomplished by performing daily intraperitoneal injections
of 3 mg/40 g body weight of tamoxifen (dissolved in corn
oil; Sigma-Aldrich) for 5 days.
For single BaCl2 injury, the mice were anesthetized
with isoflurane and the hind limbs were shaved before
the procedure. The C/EBPβfl/fl and C/EBPβ−/−Pax7C-
reER−/+ mice aged 8–10 weeks were injected with 50 μl
of 1.2% BaCl2 in PBS into the left tibialis anterior (TA)
muscle. The mice were sacrificed 4, 7, and 42 days
post injury (dpi) and the TA was collected, embedded
in Tissue-Tek OCT compound, flash frozen in isopen-
tane cooled by liquid nitrogen, and sectioned (8-μm
thick) for immunofluorescence. For double BaCl2 in-
jury, the mice were allowed to recover from a BaCl2
injury for 21 days before a second injury to the same
TA. The mice were sacrificed 7 and 21 days after the
second injury.
Primary and C2C12 myoblast culture
Primary myoblasts were isolated as described previously
[24]. Briefly, the hind limb muscles of adult (6 to 8 weeks
of age) mice were dissected and digested with collage-
nase/dispase (Roche). After digestion, the muscle slurry
was filtered through a 70-μM cell strainer to remove
undigested muscle. The cells were washed with serum-
free media and then enriched for myoblasts by magnetic-
activated cell sorting (MACS) [24]. The primary myoblasts
were grown on matrigel-coated plates in growth media
(GM: DMEM (Wisent) containing 20% FBS, 10% HS
(Invitrogen) with penicillin and streptomycin (Wisent))
supplemented with 10 ng/ml basic fibroblast growth
factor (bFGF) and 2 ng/ml human growth factor (HGF)
(Peprotech). Differentiation was induced by changing
the media of confluent cultures to differentiation media
(DM: DMEM containing 2% FBS and 10% HS) for 48 h.
To induce CreERtm activity in culture, primary myo-
blasts from wild-type and conditional knockout animals
were treated with 4-OH tamoxifen (2 μM dissolved in
100% ethanol; Sigma-Aldrich) for 48 h. To induce
Notch activity, primary myoblasts were retrovirally
transduced with empty vector (pLPCX) to express the
Notch1 intracellular domain (pLPCX-NICD) and main-
tained in growth medium.
C2C12 murine myoblasts were retrovirally transduced
with empty vector (pLXSN) or to express C/EBPβ
(pLXSN-C/EBPβ), selected based on G418 resistance, and
maintained in growth medium (DMEM with 10% FBS).
Western analysis
Whole-cell extracts from primary myoblasts were re-
solved on a 12% SDS-PAGE gel, transferred to a PVDF
membrane, and probed with specific antibodies: C/EBPβ
(E299; Abcam), Notch intracellular domain 1 (NICD1;
EMD Millipore), and cyclophilin B (Abcam). Chemilu-
minescence was detected with the ChemiDocTM MP
System (Bio-Rad Laboratories).
Limited trypsinization
Myotubes were separated from reserve cells in differenti-
ated WT and C/EBPβ−/− myoblast cultures as previously
described [25]. Briefly, myoblasts were plated on 10-cm
culture plates, cultured in GM until confluent, and then
induced to differentiate in DM for 48 h. Following differ-
entiation, myotubes were removed from reserve cells by
limited trypsinization (0.15% trypsin for 5 min). Reserve
cells, which remained attached to the culture plate, were
removed with 0.25% trypsin. Reserve cells were counted
and then re-plated to be induced for differentiation.
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Isolation and culture of single EDL myofibers
Myofibers were isolated from the extensor digitorum
longus (EDL) muscle as described previously [26]. Briefly,
the EDLs were removed from adult (6–8 weeks of age)
mice and digested with collagenase type I (2 mg/ml in
DMEM; Sigma-Aldrich). The muscles were transferred
to horse serum-coated plates, and myofibers were sepa-
rated by trituration using heat-polished glass Pasteur
pipettes. Fibers were incubated for 72 h in DMEM sup-
plemented with 15% FBS and 2% chick embryo extract
at 37 °C, 5% CO2.
Immunofluorescence
Myofibers were fixed in 4% paraformaldehyde (PFA) in
PBS and 1% glycine and blocked in PBS containing 0.2%
Triton X-100 (BioShop), 2% BSA, 5% goat serum
(Cedarlane), and 1% azide. Myoblasts were fixed in 2%
PFA in PBS and blocked in PBS containing 0.3% Triton
X-100 and 10% goat serum. Cryosections were thawed at
room temperature, fixed in 4% PFA, and processed for
antigen retrieval in citrate buffer at 95 °C for 20 min.
The sections were permeabilized with PBS containing
0.5% Triton X-100 and blocked in PBS containing 0.1%
Triton X-100 and 5% donkey serum (Cedarlane) prior to
incubation with primary antibody overnight at 4 °C. The
cells were washed with PBS and incubated in biotin anti-
mouse (when indicated) or secondary antibodies conju-
gated to a fluorescent dye (Cy3, Alexa 488, or Alexa
Flour 647; all from Jackson ImmunoResearch). Nuclei
were counterstained with DAPI (0.5 μg/ml). The primary
antibodies used were as follows: Pax7-c (DSHB), MYH
(H-300; Santa Cruz), MyoD (C-20; Santa Cruz), myo-
genin (M-225; Santa Cruz), C/EBPβ (E299; Abcam), and
laminin (AL-4; Millipore).
Image acquisition
Digital images of the stained myoblasts, myofibers, and
muscle sections were acquired at room temperature
using a microscope (Leica DM 3000B), Infinity-3 camera
(Lumenera), and Infinity Capture imaging software
(Lumenera). The images were composed and edited in
paint.net.
Chromatin immunoprecipitation
C2C12 myoblasts were crosslinked for 30 min at room
temperature with 1% formaldehyde and sonicated with
Diagenode bioruptor®. Chromatin immunoprecipitation
(ChIP) analysis was performed as described [27] using
antibodies against C/EBPβ (C-19; Santa Cruz) or rabbit
IgG as negative control. Protein G conjugated Dynabeads
(Invitrogen) were used to precipitate immunoconjugates,
and DNA fragments were purified using the QIAquick
PCR purification kit (Qiagen). A standard curve was gen-
erated using input DNA for each immunoprecipitate, and
quantification was determined as the percentage of en-
richment relative to 10% input for each condition. Primer
sequences for qPCR amplification are as follows: Notch2
R1 (–19 kb; chr3:97,797,949-97,798,354) F: TGAGGAAG
TTGACAGGGAGC, R: GTGTCCAGGGCAACTTGG
AA; Notch2 R2 (+11 kb; chr3:97,828,475-97,828,573) F:
GGAAGCGATCGGTGTTGTTG, R: AAAAGCAGTGG
GGCGTCTTA; Notch2 R3 (+14 kb; chr3:97,831,399-9
7,831,590) F: TAGGAAGGATGTGGGGAGGG, R: ATCT




Statistical analysis was performed using GraphPad Prism
software (GraphPad Software, La Jolla, CA, USA). A
student’s t test was used when comparing a single
experimental condition to the control condition. A one-
way ANOVA was performed when comparing three or
more experimental conditions. A Tukey’s post hoc test
was used when the ANOVA was significant. The cutoff
for significance was p < 0.05. All experiments are repre-
sentative of a minimum of three biological replicates,
and data is presented as mean ± standard error mean
(SEM).
Results
C/EBPβ-deficient satellite cells display increased
differentiation
To investigate the functional consequences of disrupting
C/EBPβ expression in SCs, we isolated SCs from condi-
tional knockout mice (Cebpbfl/flPax7CreER/+) in which
C/EBPβ expression is abrogated in Pax7+ cells follow-
ing activation of the CreER recombinase with tamoxi-
fen. SC-derived myoblasts (Cebpbfl/flPax7+/+ (WT)
and C/EBPβ−/−) were cultured in high serum (GM) for
24 h, and excision was confirmed by RT-qPCR, with
Cebpb expression reduced to ~10% of controls
(Fig. 1a). In C/EBPβ−/− cells, Pax7 expression was sig-
nificantly reduced by approximately 50% as compared
to the WT controls, while Myod1 and Myog expression
were unaffected (Fig. 1b). As C/EBPβ is a known regu-
lator of Pax7 and MyoD protein expression, the pro-
portion of self-renewing (Pax7+/MyoD−), proliferating
(Pax7+/MyoD+), and differentiating (Pax7−/MyoD+)
cells was assessed in WT and C/EBPβ−/− myoblasts in
growth medium by immunostaining (Fig. 1c) [19]. The
percentage of Pax7+/MyoD− (self-renewing) cells was
decreased in C/EBPβ−/− myoblasts compared to WT myo-
blasts (2.9 vs. 5.2%) with a concomitant increase in
Pax7−/MyoD+ differentiating cells (16.2 vs. 8.8%)
(Fig. 1d, e). There was no significant change in the
population of Pax7+/MyoD+ proliferating cells between
C/EBPβ−/− myoblasts and WT myoblasts in GM (Fig. 1f).
Lala-Tabbert et al. Skeletal Muscle  (2016) 6:40 Page 3 of 11
Given the larger population of Pax7−/MyoD+ cells in
C/EBPβ−/− cultures, we assessed myogenin expression by
immunostaining. While no significant differences were
observed in mRNA expression over the population
(Fig. 1b), there was a significant ~2-fold increase in the
percentage of myogenin-positive cells in C/EBPβ−/−
myoblast cultures as compared to WT (Fig. 1g, h) sug-
gesting that C/EBPβ-deficient cells are more predisposed
to precociously differentiate under growth conditions,
consistent with our previous findings [19].
To further investigate C/EBPβ-dependent alteration in
cell fate choices, we used single myofiber preparations
isolated from the EDL muscles of wild-type (WT) and
conditional null (C/EBPβ−/−) animals 1 week after daily
tamoxifen (3 mg/40 g body weight for 5 days) injections
to induce excision. C/EBPβ excision was confirmed by
western blot of cell lysates from satellite cells isolated
from the hind limb muscles (except EDL) of the
tamoxifen-treated animals (Fig. 2a). Myofibers from the
WT and C/EBPβ−/− mice were immunostained for Pax7
and MyoD and counterstained with DAPI to determine
the number of self-renewing (Pax7+/MyoD−), activated
(Pax7+/MyoD+), and differentiated (Pax7−/MyoD+) SCs
72 h after isolation. The myofibers from the C/EBPβ−/−
animals had significantly fewer Pax7+/MyoD− SCs
(10.4%) and more Pax7−/MyoD+ SCs (38.3%) compared
to WT EDL myofibers (28.1 and 18.9%, respectively)
without affecting the proliferating Pax7+/MyoD+ popula-
tion (Fig. 2b, c). Furthermore, when immunolabeled for
Pax7 and myogenin, the myofibers from the C/EBPβ−/
− animals had significantly more myogenin+ cells
(59%) compared to the control EDL myofibers (34%)
(Fig. 2d, e). There were no changes in the number of
satellite cells per cluster on WTand C/EBPβ−/− myofibers,
confirming that loss of C/EBPβ does not inhibit SC activa-
tion (Fig. 2f). These results further demonstrate that C/
EBPβ promotes SC self-renewal and that loss of C/EBPβ
in SCs leads to increased differentiation.
C/EBPβ is required for the generation of reserve cells in
vitro
To examine the role of C/EBPβ in SC self-renewal during
myogenic differentiation, SC-derived myoblasts (wild-type
and C/EBPβ−/−) were cultured in high serum (GM) for
24 h and then switched to low serum (DM) for 48 h to in-
duce differentiation. RT-qPCR analysis confirmed excision
of Cebpb in the myoblasts isolated from the C/EBPβ−/−
animals (Fig. 3a). Terminally differentiated cultures were
fixed and stained for myosin heavy chain (MyHC) and
Pax7 expression to quantify myoblast fusion and reserve
cell formation, respectively (Fig. 3b) [25, 28]. The differen-
tiated C/EBPβ-null cultures had fewer Pax7+ reserve cells
(2.8%) compared to the control cultures (8.2%) (Fig. 3b, c)
consistent with the reduction of Pax7+/MyoD− cells
observed in GM (Fig. 1d). Pax7+ reserve cells can be sepa-
rated from myotubes by limited trypsinization and differ-
entiated again to study self-renewal dynamics in a cell
population [25, 28]. To determine whether C/EBPβ−/−
Fig. 1 Loss of C/EBPβ reduces the proportion of Pax7+ cells in
myogenic cultures. a RT-qPCR analysis of Cebpb expression in
primary myoblasts isolated from C/EBPβfl/flPax7+/+ (wild-type) and
conditional null C/EBPβ−/−Pax7CreER−/+ (C/EBPβ−/−) subjected to in vitro
4′OH-TAM treatment and cultured in growth medium (GM) (n = 5).
b RT-qPCR analysis of Pax7, Myod1, and Myog expression in primary
myoblasts isolated and cultured as in a (n= 5). c Representative pictures
of myoblasts cultured under growth conditions for 24 h stained for
Pax7 (red) and MyoD (green). Nuclei were counterstained with DAPI
(blue). Scale bar, 50 μm. Percentage of d self-renewing (Pax7+/MyoD−),
e differentiating (Pax7−/MyoD+), and f proliferating (Pax7+/MyoD+) WT
(black bars) and C/EBPβ−/− (white bars) myoblasts cultured as in a as
determined by immunocytochemistry (n = 4). g Representative
pictures of cells cultured as in a and immunostained for myogenin
(red). The nuclei were counterstained with DAPI (blue). Scale bar,
50 um. h Percentage of myogenin+ cells relative to total nuclei (n = 4).
For all panels, data is represented as mean ± SEM,
*p < 0.05, ***p < 0.001
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reserve cells function normally, we collected reserve cells
by limited trypsinization and, after expansion and equal
plating, induced them to differentiate. After each round of
differentiation, we counted the total number of reserve
cells. After each passage, despite equal plating, there were
fewer C/EBPβ−/− reserve cells compared to wild-type cells
(Fig. 3d). Further, after each round of differentiation, the
number of reserve cells trended towards a decrease in the
C/EBPβ−/− cultures but did not achieve statistical signifi-
cance (Fig. 3d). These data suggests that C/EBPβ is
required for maintenance of reserve cells in vitro.
C/EBPβ is required to restore the muscle satellite cell pool
during regeneration
To confirm the reduced self-renewal potential of C/EBPβ−/
− satellite cells in vivo, an acute injury was induced by BaCl2
injection into the TA muscle of the C/EBPβfl/flPax7+/+
(wild-type) and conditional null C/EBPβ−/−Pax7CreER−/+ (C/
EBPβ−/−) animals 1 week after tamoxifen administration
(3 mg/40 g body weight daily for 5 days). The TA muscles
were collected 0, 4, 7, and 42 dpi (Fig. 4a). Excision was
confirmed by dual immunofluorescence staining of TA
muscle sections for Pax7 and C/EBPβ (Fig. 4b, c). Immuno-
staining of injured TA muscle at 0, 4, and 7 dpi for Pax7
revealed that there were no changes in the number of Pax7
+ cells in the C/EBPβ-deficient muscle compared to the
wild-type muscle (Fig. 4d, e), suggesting that C/EBPβ-defi-
cient myoblasts expand efficiently after muscle injury.
During postnatal regeneration, the size of the Pax7+
satellite cell pool reaches homeostatic levels observed in
the uninjured muscle 40 days after injury [29]. In the
wild-type muscle, Pax7+ cell numbers returned to non-
injured levels; however, there were significantly fewer
Pax7+ cells in C/EBPβ-null muscle (Fig. 4d, f ). These
Fig. 2 Loss of C/EBPβ inhibits satellite cell self-renewal and promotes differentiation. C/EBPβfl/flPax7+/+ (wild-type) and conditional null C/EBPβ−/−Pax7C-
reER−/+ (C/EBPβ−/−) mice were injected daily with tamoxifen for 5 days. One week after the last injection, myofibers were isolated from the EDL of each
mouse and cultured for 3 days in suspension before immunostaining. a Western analysis of C/EBPβ expression in SCs isolated from the hind limb of
WT and C/EBPβ−/− mice injected with tamoxifen for 5 days. b Representative pictures of myofibers stained for Pax7 (red) and MyoD (green). Nuclei were
counterstained with DAPI (blue). Scale bar, 20 μm. c Quantification of self-renewing (Pax7+/MyoD−), proliferating (Pax7+/MyoD+), and differentiating
(Pax7−/MyoD+) myoblasts on single myofibers (n = 4 mouse pairs). d Representative pictures of myofibers stained for Pax7 (red) and myogenin (green).
Nuclei were counterstained with DAPI (blue). Scale bar, 20 μm. e Quantification of myogenin+ cells as a percentage of total nuclei (n = 3 mouse pairs).
f Total number of cells per cluster (n = 3 mouse pairs). For all panels, data is represented as mean ± SEM, *p < 0.05, **p < 0.01, n.s. not significant
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findings suggest that C/EBPβ is essential for directing
cells towards self-renewal after injury.
Loss of C/EBPβ expression cripples the long-term
regenerative response
As SC self-renewal is essential for efficient repair of
tissue after injury, we examined muscle regeneration in
wild-type and conditional null (C/EBPβ−/−) animals after
two serial BaCl2 injuries separated by 21 days. TA mus-
cles were collected 7 and 21 days after the second injury
for analysis (Fig. 5a). One week following double injury
(7 dpi), the TA muscle sections were stained for embry-
onic myosin heavy chain (eMyHC) to measure the size
of newly regenerated fibers. Contrary to what was
observed after a single injury [19], the average cross-
sectional area of eMyHC+ fibers was significantly smaller
in the C/EBPβ−/− muscle (348 μm) compared to the
wild-type muscle (661 μm) (Fig. 5b, c). There were also
fewer Pax7+ cells in the C/EBPβ-deficient muscle com-
pared to the wild-type muscle (Fig. 5d). To confirm that
the smaller fiber size in C/EBPβ-null animals was not
due to a delay in regeneration, we assessed the average
cross-sectional area of fibers 21 days after secondary in-
jury (21 dpi). Consistent with our 7 dpi findings, muscle
fibers from the C/EBPβ−/− animals were smaller (1353
um) compared to the wild-type fibers (1703 μm) (Fig. 5e,
f ) and the percentage of Pax7+ SCs remained lower in
C/EBPβ-deficient muscle (Fig. 5g). Taken together, these
results strongly suggest that C/EBPβ is essential for SC
self-renewal that is necessary for continual muscle
regeneration.
Activation of Notch signaling rescues self-renewal in
C/EBPβ-deficient myoblasts
The Notch pathway is an established regulator of SC self-
renewal and homeostasis [30–33]; thus, we examined
whether the expression of Notch1 intracellular domain
(NICD) and Notch target genes (Hey1, Heyl) were dis-
rupted in C/EBPβ−/− myoblasts grown in GM. Western
analysis revealed that the amount of the activated Notch
(NICD) was decreased in the C/EBPβ−/− myoblasts as
compared to the control myoblasts (Fig. 6a). Consistent
with the reduced NICD, RT-qPCR revealed that the ex-
pression of the Notch target genes Hey1 and Heyl was sig-
nificantly downregulated in myoblasts deficient in C/EBPβ
compared to wild-type myoblasts (Fig. 6b).
Since Notch signaling is reduced in C/EBPβ−/− myo-
blasts and Notch signaling is known to inhibit myogenic
differentiation, we examined whether precocious differ-
entiation in these cells could be rescued by NICD over-
expression. Western analysis confirmed C/EBPβ excision
and NICD overexpression in WT and C/EBPβ−/− myo-
blasts retrovirally transduced to express the NICD or
with empty vector (pLP) (Fig. 6c). While the population
of Pax7+/MyoD− cells was significantly reduced with the
loss of C/EBPβ expression, this population was restored
to control levels with expression of the NICD (Fig. 6d).
There were no significant changes in the Pax7+/MyoD+
population, but NICD overexpression prevented the pre-
cocious differentiation (Pax7−/MyoD+) observed in C/
EBPβ−/− myoblasts (Fig. 6e, f ). Myogenin staining con-
firmed this finding (Fig. 6g), suggesting that the loss of
self-renewal in C/EBPβ−/− myoblasts is due to decreased
Notch signaling.
To determine how C/EBPβ regulates Notch signaling,
we assessed Notch receptor expression (Notch1, Notch2,
and Notch3) in wild-type and C/EBPβ−/− myoblasts, as
well as, C2C12s retrovirally transduced to overexpress
C/EBPβ or with empty vector (pLXSN). RT-qPCR ana-
lysis revealed that both Notch2 and Notch3 were signifi-
cantly downregulated in C/EBPβ−/− myoblasts in the
growth medium, while Notch1 expression was reduced
but failed to reach statistical significance (Fig. 6h). In
proliferating C2C12s overexpressing Cebpb, Notch2 was
the only Notch receptor significantly upregulated as
compared to empty virus controls (Fig. 6i, j), suggesting
that Notch2 is regulated by C/EBPβ in myoblasts. We
next examined whether C/EBPβ could occupy DNA
Fig. 3 Loss of C/EBPβ leads to a reduction in reserve cells in vitro. a
RT-qPCR analysis of Cebpb expression in primary myoblasts isolated
from C/EBPβ conditional knockout mice (C/EBPβ−/−) or wild-type non-
Cre-expressing littermates subjected to in vitro 4’OH-TAM treatment,
cultured in GM, and plated and transferred to differentiation media for
48 h (n= 3). b Representative pictures of cells stained for myosin heavy
chain (MyHC; green) and Pax7 (red). Nuclei were counterstained with
DAPI (blue). Scale bar, 50 μm. c Percentage of Pax7+ cells relative to total
nuclei (n= 3). d Reserve cells were collected and counted following
limited trypsinization after 48 h in differentiation media. After counting,
the reserve cells were expanded, re-plated at equal densities, and
induced to differentiate in low serum for another 48 h. The number of
reserve cells was counted after each round of differentiation and
represented as a percentage of total nuclei (n = 3). Data is represented
as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001
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regulatory elements controlling Notch2 expression.
Using available ChIP-seq data (GSE36024), we identified
four peaks of C/EBPβ binding (E1–E4) of which E3 is a
known Notch2 enhancer [34] and assessed C/EBPβ
occupancy of these regions by chromatin immunopre-
cipitation (Fig. 6k). Under growth conditions, we found
that C/EBPβ could occupy all of the regions identified
by ChIP-seq, suggesting that CEBPβ can control entry
into differentiation and self-renewal, at least in part,
through regulation of Notch2 expression and Notch
activity.
Discussion
While most activated satellite cells will progress through
myogenic differentiation, a small fraction escape, return
to quiescence, and self-renew to maintain the muscle stem
Fig. 4 C/EBPβ is required for restoring the muscle stem cell pool after acute injury. a Experimental design. C/EBPβfl/fl Pax7+/+ (wild-type) and conditional
null C/EBPβ−/−Pax7CreER−/+ (C/EBPβ−/−) mice were injected daily with tamoxifen for 5 days. One week after the last injection, the left tibialis anterior (TA)
muscle was injured by intramuscular injection of 50 μl of 1.2% BaCl2. The muscle was analyzed at 0, 4, 7, and 42 days post injury (dpi). b Cross-sections of
uninjured TA were immunostained for Pax7 (red), C/EBPβ (green), and laminin (white). Nuclei were counterstained with DAPI (blue). Representative pictures
are shown. Scale bar, 20 μm. c Excision efficiency in Cre+ satellite cells represented by the percentage of C/EBPβ+ nuclei among total Pax7+ cells in
uninjured muscle (n= 3). d Cross-sections of injured TA 0, 4, 7, and 42 dpi were immunostained for Pax7 (red) and counterstained with DAPI (blue).
Representative pictures are shown. Scale bar, 20 μm. e Pax7+ cells per area (mm2) at 0, 4, and 7 dpi (n≥ 3 mouse pairs). f Pax7+ cells per area (mm2) at 42
dpi (n= 4 mouse pairs). For all panels, data is represented as mean ± SEM, *p <0.05, **p< 0.01, n.s. not significant
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cell population, marked by loss of MyoD expression. In
addition to downregulation of MyoD expression, it is
known that the SC population itself is heterogeneous and
can undergo both asymmetrical and symmetrical divisions
in the context of the niche, with asymmetric distribution
of cellular proteins and chromatin templates which regu-
late the balance between SC maintenance and regenerative
potential. Analysis of myogenic regulatory factor (Myf5
and MyoD) expression in proliferating SCs revealed asym-
metric expression of these factors in newly divided daugh-
ter cells [35–37]. These multiple mechanisms implicated
in the maintenance of the skeletal muscle stem cell pool
underlie the importance of these cells for muscle homeo-
stasis. Too many cells destined towards repair results in
rapid depletion of the SC compartment as observed with
the loss of C/EBPβ, while enhanced self-renewal restrains
regeneration, with both disequilibria leading to muscle at-
rophy. Recently, loss of dystrophin expression in SCs in
Duchenne muscular dystrophy was shown to reduce the
available pool of SCs for repair, contributing to the patho-
genesis of this disease [38].
While self-renewal is important for maintaining the
precursor pool, the mechanisms by which some SCs
evade differentiation remain poorly understood. In this
study, we identify C/EBPβ as a novel regulator of SC
self-renewal, demonstrating that in its absence, Pax7
+/MyoD− cells are generated in lesser number, resulting
in a reduction of the satellite cell pool. While muscle in
the conditional nulls repairs with greater efficiency after
a single injury due to an increased propensity to differ-
entiate [19], this repair results in a significant decrease
in the SC population that cannot efficiently support
repair after a second injury. However, using our condi-
tional model, we observed a reduction in the satellite cell
pool, rather than depletion, attributable to the incom-
plete excision of Cebpb and therefore the contribution
of recombination escapers.
C/EBPβ is normally downregulated in early differenti-
ation, a step that is required for full expression of MyoD
and differentiation to occur [19]. Indeed, loss of C/EBPβ
expression does not affect the progression towards the
Pax7+/MyoD+ state. It remains unclear whether C/EBPβ
is asymmetrically distributed in proliferating myoblasts
or whether its expression is re-initialized in a small
population of Pax7+ cells destined to self-renew. Indeed,
while C/EBPβ expression does not appear to be required
for Pax7 expression [19], it can force Pax7 to be
expressed under differentiation conditions, and this
mechanism could prevent myoblasts from completing
myogenic differentiation. Many studies have demonstrated
Fig. 5 Loss of C/EBPβ expression in satellite cells decreases regenerative capacity following serial injury. a Experimental design. C/EBPβfl/fl Pax7+/+
(wild-type) and conditional null C/EBPβ−/−Pax7CreER−/+ (C/EBP β−/−) mice were injected daily with tamoxifen for 5 days. One week after the last injection,
the left tibialis anterior (TA) muscle was injured using 50 μl of 1.2% BaCl2 (1st injury). Twenty-one days after the initial injury, the same TA muscle was
injured again using 50 μl of 1.2% BaCl2 (2nd injury). The muscle was analyzed at 7 and 21 days after the 2nd injury (dpi). b Cross-sections of injured TA 7
dpi were stained with embryonic myosin heavy chain (eMyHC; red) and laminin (LAM; green). Nuclei were counterstained with DAPI (blue). Representative
pictures are shown. Scale bar: 50 μm. c Average cross-sectional area of eMyHC+ fibers from TA sections stained as in b (n= 5 mouse pairs). d Pax7+ nuclei
were counted in 7 dpi muscle and represented as total Pax7+ cells per area (mm2) (n= 4 mouse pairs). e Cross-sections of injured TA 21 dpi were stained
for hematoxylin (nuclei; purple) and eosin (pink) (H&E). Representative pictures are shown. Scale bar, 50 μm. f Average cross-sectional area of myofibers from
TA sections stained as in e (n= 6 mouse pairs). g Pax7+ nuclei were counted in 21 dpi muscle and represented as total Pax7+ cells per area (mm2) (n= 3
mouse pairs). Data is represented as mean ± SEM, *p< 0.05, **p< 0.01
Lala-Tabbert et al. Skeletal Muscle  (2016) 6:40 Page 8 of 11
that adult skeletal muscles lacking Pax7-expressing satel-
lite cells cannot regenerate [2, 39, 40].
A number of signaling pathways have been implicated
in SC self-renewal. Recent literature suggests that
Notch signaling is crucial for SCs to self-renew and
return to quiescence [30–33]. In adult muscle, the
absence of Notch signaling induced spontaneous activa-
tion and differentiation of SCs which lead to a reduc-
tion in self-renewal and consequently impaired muscle
regeneration [31, 32]. Furthermore, overexpression of
Notch intracellular domain (NICDOE) upregulates
Pax7, downregulates MyoD, and inhibits S-phase entry
of primary myoblasts [33]. SC specific NICDOE also im-
paired regeneration of skeletal muscle [33] and loss of
downstream Notch target genes Hesr1 (Hey1) and
Hesr3 (HeyL) led to precocious differentiation, reduced
SC self-renewal, and a reduced SC pool [30]. Interest-
ingly, we show that the loss of C/EBPβ in SC-derived
myoblasts results in a significant downregulation in
genes involved in the Notch signaling pathway (Fig. 6)
suggesting one possible mechanism by which C/EBPβ
regulates SC self-renewal is through regulation of
Notch. Indeed, changes in C/EBPβ expression induced
changes in both Notch receptor expression and Notch
activity as measured by Hey1 and Heyl expression.
While we identify Notch2 as a target of C/EBPβ activ-
ity, we demonstrate that the Notch1 intracellular do-
main is also reduced, suggesting that C/EBPβ may
regulate the Notch pathway at multiple levels. Re-
cently, over-activation of Notch signaling was shown
in progenitor cells in skeletal muscle of dystrophic
mice [41]. We have shown that C/EBPβ expression
persists in SCs of cachectic muscles and that these
cells do not differentiate [42, 43]; thus, it is tempting
to hypothesize that C/EBPβ may persist in SCs of dys-
trophic muscle, upregulating Notch expression and
contributing to the dystrophic defect. Our findings
provide a mechanism for C/EBPβ-induced cell fate
Fig. 6 Activation of Notch signaling rescues self-renewal in C/EBPβ-deficient myoblasts. a Western analysis of C/EBPβ and NICD expression in primary
myoblasts isolated from C/EBPβ conditional knockout mice (β−/−) or wild-type non-Cre-expressing littermates (WT) subjected to in vitro 4′OH-TAM
treatment and cultured in growth medium (GM). Cyclophilin B (CyPB) is a loading control. b RT-qPCR analysis of Hey1 and Heyl expression in primary
myoblasts isolated and cultured as in a (n = 5). c C/EBPβ and Notch1 intracellular domain (NICD) protein expression in wild-type (WT) and C/
EBPβ−/− (cKO) primary myoblasts retrovirally transduced to express NICD or with empty virus (pLPCX; pLP) cultured in GM for 48 h (n = 3).
Percentage of d self-renewing (Pax7+/MyoD−), e proliferating (Pax7+/MyoD+), and f differentiating (Pax7−/MyoD+) WT (black bars), WT + NICD
(blue bars), C/EBPβ−/− (white bars), and C/EBPβ−/− + NICD (orange bars) myoblasts cultured as in c as determined by immunocytochemistry
(n = 3). g Percentage of myogenin+ cells relative to total nuclei (n = 3). h RT-qPCR analysis of Notch1, Notch2, and Notch3 expression in primary
cells transduced to express C/EBPβ and cultured as in a, shown relative to WT controls indicated by the red line (n = 5). i Cebpb and j Notch1,
Notch2 and Notch3 expression in C2C12s retrovirally transduced to express C/EBPβ relative to empty vector controls (pLXSN, red line) cultured
in growth medium for 24 h (n= 4). k ChIP analysis of C/EBPβ occupancy at four regions (R1–R4) of the Notch2 locus in C2C12s retrovirally transduced to
express C/EBPβ or empty vector (pLXSN) in GM. RT-qPCR data is shown as the percent enrichment relative to 10% input used for immunoprecipitation for
each condition (n= 4). Approximate region locations are relative to the transcriptional start site. Data is represented as mean ± SEM, *p< 0.05, **p< 0.01,
***p< 0.001. Means with different letters are significantly different
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choices in myogenesis and identify C/EBPβ as a novel
regulator of Notch signaling.
Conclusions
C/EBPβ-deficient satellite cells are unable to efficiently
self-renew after muscle injury, leading to a reduction in
the SC pool and impaired regenerative capacity after serial
injury. Taken together, our results establish C/EBPβ as a
novel regulator of SC homeostasis that promotes differen-
tiation at the expense of self-renewal. For example, while
increased expression of C/EBPβ in cachectic muscle
inhibits repair of wasting fibers, C/EBPβ protects the stem
cells from apoptosis. The characterization of transcription
factors controlling SC homeostasis provides important
insights into the molecular mechanisms regulating skeletal
muscle regeneration and further insight into the regula-
tion of C/EBPβ function, and its biological role in the
context of healthy and diseased muscle can fuel the devel-
opment of novel therapeutic approaches for the treatment
of muscle atrophies.
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